MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 207 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $372,868 | +16.1% | 15,244 | +1.2% | 0.00% | 0.0% |
| Q1 2024 | $321,164 | -36.9% | 15,064 | -43.3% | 0.00% | -50.0% |
| Q4 2023 | $508,665 | +18.4% | 26,576 | -0.8% | 0.00% | 0.0% |
| Q3 2023 | $429,599 | +347.5% | 26,783 | +408.0% | 0.00% | +100.0% |
| Q2 2022 | $96,000 | -25.0% | 5,272 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $128,000 | +85.5% | 5,083 | +103.2% | 0.00% | – |
| Q4 2021 | $69,000 | -16.9% | 2,502 | -2.5% | 0.00% | -100.0% |
| Q3 2021 | $83,000 | +7.8% | 2,567 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | -6.1% | 2,526 | -6.5% | 0.00% | 0.0% |
| Q1 2021 | $82,000 | +2633.3% | 2,703 | +1764.1% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 145 | -76.1% | 0.00% | – |
| Q3 2020 | $8,000 | +33.3% | 607 | +13.0% | 0.00% | – |
| Q2 2020 | $6,000 | -60.0% | 537 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $15,000 | – | 537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |